AROAF.US Aroa Biosurgery Limited

Healthcare Medical Devices USA Stocks
0.4726 USD
Close of Nov 14, 2026
0.3845 0.5220
Market cap
USD 166M
P/E
47.3x
P/B
2.91x
ROE
4.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Mar 2026.

Is AROAF.US undervalued?

Graham number
Price0.4726
Graham value0.1911
Premium147.4%

AROAF.US trades 147.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Aroa Biosurgery Limited fundamental analysis

No fundamental analysis for Aroa Biosurgery Limited yet.

Aroa Biosurgery Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Aroa Biosurgery Limited

Aroa Biosurgery Limited develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobial Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; and Myriad Morcells, Myriad Morcells Fine, Myriad Meshed, and Symp…

Full company profile